Results 51 to 60 of about 9,103,151 (355)

Drug Policy in Latvia [PDF]

Value in Health Regional Issues, 2017
We present a general overview of the health care system as well as the pricing and reimbursement environment in Latvia. Overall, the pharmaceutical sector in Latvia, including pricing and reimbursement, is strictly regulated. The main Latvian stakeholder in the pharmaceutical sector is the Ministry of Health.
Janis, Silins, Monika, Szkultecka-Dębek
openaire   +2 more sources

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Heterogeneity of Illegal Markets: A Book Review Essay

Journal of Illicit Economies and Development, 2019
Literature on the economic-sociology of illegal markets is progressing convincingly, as scholars identify the need to investigate illegality through the perspective of the market, as well as through the perspective of the actor. In this book review essay,
Hamish Richardson
doaj   +1 more source

TOWARDS A COMPASSIONATE AND COST-EFFECTIVE DRUG POLICY: A FORUM ON THE IMPACT OF DRUG POLICY ON THE JUSTICE SYSTEM AND HUMAN RIGHTS [PDF]

, 1997
This is a transcript from the the first of three panels on drug policy and the impact of drug policy on the justice system and human rights. Don Johnson of the New York Society for Ethical Culture and Tom Haines the Chairman of the Executive Committee ...

core   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Drug policy and Collective Health: necessary dialogues.

Cadernos de Saúde Pública, 2019
The current status of policies on illicit drugs has implications for Collective Health that need to be discussed in depth. This essay aims to explore, in light of the best evidence, the public health impact of drug policies focused on the criminalization
Débora Gomes-Medeiros, Pedro Henrique de Faria, G. W. Campos, Luís Fernando Tófoli   +3 more
semanticscholar   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

People who use drugs and the right to health

Harm Reduction Journal
Support for a human rights framework for drug policy has been growing for some years. This year, the UNODC published a chapter in the World Drug Report focussed on the right to health.
Alison Ritter, Liz Barrett
doaj   +1 more source

Branded prescription drug spending: a framework to evaluate policy options

Journal of Pharmaceutical Policy and Practice, 2017
Background High drug spending is a concern for policy makers due to limits on access for patients. Numerous policies have been proposed to address high drug spending.
Jeromie Ballreich, G. Caleb Alexander, Mariana Socal, Taruja Karmarkar, Gerard Anderson   +4 more
doaj   +1 more source

Drug Policy in Poland [PDF]

Value in Health Regional Issues, 2017
We presented a general overview of the health care system as well as the pricing and reimbursement environment in Poland. Poland aims to ensure proper access to safe and effective medicines while reducing patients' share in treatment costs. Nevertheless, the co-payment for pharmacotherapy is still high (more than 60%). The key policymaker and regulator
Karina, Jahnz-Różyk, Pawel, Kawalec, Krzysztof, Malinowski, Katarzyna, Czok   +3 more
openaire   +3 more sources